This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

BofA: Analysts' Upgrades, Downgrades

General Electric (GE) numbers raised at Morgan Stanley through 2010. Company should continue to deliver strong cash earnings. Overweight rating and new $20 price target.

Genzyme (GENZ) estimates, target lowered at Morgan Stanley. Shares now seen reaching $58. Estimates also cut, as R&D spending remains high and the company will ultimately lose some lucrative patents. Equal-weight rating.

Corning (GLW) estimates raised at Goldman through 2011. Company should benefit from strong demand for PC's and LCD TV sales. Neutral rating and $17 price target.

Genuine Parts (GPC) numbers lowered at Goldman to $41. Estimates also cut, to reflect lower realized EBIT margins. Neutral rating.

Harley-Davidson (HOG - Get Report) estimates, target boosted at Goldman. Shares of HOG now seen reaching $23. Estimates also raised, to reflect better operating performance in the core motorcycle business. Neutral rating.

Mastercard (MA) estimates raised at Goldman through 2010. Margins are improving, as the consumer remains steady and currency trends are improving. Buy rating and $250 price target.

Merck (MRK) price target up, estimates down at Barclays. Price target raised to $34 from $31. 2009 and 2010 EPS estimates cut to $3.22 from $3.27 and to $3.40 from $3.41, respectively. Reiterate Overweight rating.

Netflix (NFLX) price target raised at Thomas Weisel to $57 from $51. Reiterate Overweight rating. 2009 and 2010 EPS estimates set at $1.77 and $2.07, respectively.

Pfizer (PFE) estimates raised at Credit Suisse. PFE 2009 and 2010 EPS estimates to $2.01 from $1.99 and to $2.42 from $2.23, respectively. Maintain Outperform rating and $21 price target.
4 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ACN $114.39 1.30%
BAC $14.77 1.40%
CCOI $39.26 1.40%
HAL $41.60 0.70%
HOG $48.32 1.00%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs